Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
21,509 Breast Cancer
clinical trials

Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
FirstHealth of the Carolinas - FirstHealth Outpatient Cancer Center
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Woodland Hills
mi
from
Woodland Hills, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Pali Momi Medical Center
mi
from
'Aiea, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
The Cancer Center of Hawaii-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
McLaren Cancer Institute-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Newland Medical Associates-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Walter Knox Memorial Hospital
mi
from
Emmett, ID
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Genesee Hematology Oncology PC
mi
from
Flint, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Grosse Pointe Woods
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lehigh Valley Hospital-Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Cancer Care Inc-Liliha
mi
from
Honolulu, HI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Union County
mi
from
New Albany, MS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakeland Hospital Niles
mi
from
Niles, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Hematology Associates of Saginaw Valley PC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of West Branch
mi
from
West Branch, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Lakes Medical Center
mi
from
Wyoming, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
Status: Enrolling
Updated: 12/31/1969
Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) at Milford Regional Medical Center
mi
from
Milford, MA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
Status: Enrolling
Updated: 12/31/1969
Lifespan / Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
Delphinus SoftVue Prospective Case Collection - ARM 1
Status: Enrolling
Updated: 2/7/2018
Lee Breast Center, USC Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
Delphinus SoftVue Prospective Case Collection - ARM 1
Status: Enrolling
Updated: 2/7/2018
Weinstein Imaging
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
Delphinus SoftVue Prospective Case Collection - ARM 1
Status: Enrolling
Updated: 2/7/2018
SouthCoast Imaging
mi
from
Savannah, GA
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Anchorage, AK
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Mayo Clinic Jacksonville -- Center for Breast Health
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic or Inoperable Locally Advanced Triple-Negative Breast Cancer (Morpheus-TNBC)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Peter MacCallum Cancer Centre-East Melbourne
mi
from
Melbourne,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Exercise, Fitness and Tumor Profiling in Breast Cancer Patients
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Akron General
mi
from
Akron, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
McFarland Clinic PC - Ames
mi
from
Ames, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Duluth Clinic Ashland
mi
from
Ashland, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Wisconsin Cancer Center
mi
from
Ashland, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
UM Upper Chesapeake Medical Center
mi
from
Bel Air, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
mi
from
Caldwell, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health - Deer River Clinic
mi
from
Deer River, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
UM Baltimore Washington Medical Center/Tate Cancer Center
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Hibbing Clinic
mi
from
Hibbing, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health - Jamestown Clinic
mi
from
Jamestown, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Good Samaritan Medical Center
mi
from
Lafayette, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Condell Memorial Hospital
mi
from
Libertyville, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Monticello Cancer Center
mi
from
Monticello, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
PeaceHealth United General Medical Center
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Southwest Illinois Health Services LLP
mi
from
Swansea, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Richard M Schulze Family Foundation Outpatient Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
National Jewish Health-Northern Hematology Oncology
mi
from
Thornton, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Virginia Clinic
mi
from
Virginia, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Wellspan Health - York Cancer Center
mi
from
York, PA
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Hawaii Oncology Inc-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Trinity Regional Medical Center
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Tidelands Georgetown Memorial Hospital
mi
from
Georgetown, SC
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Health Care Germantown Health Center
mi
from
Germantown, WI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Great Bend
mi
from
Great Bend, KS
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Hawaii Cancer Care Inc-POB II
mi
from
Honolulu, HI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwell Health- Center for Advanced Medicine
mi
from
Lake Success, NY
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Hope Cancer Clinic
mi
from
Livonia, MI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Bay Area Medical Group-Marinette
mi
from
Marinette, WI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Monticello Cancer Center
mi
from
Monticello, MN
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Rochester Hills
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser San Rafael-Gallinas
mi
from
San Rafael, CA
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
HSHS Saint Nicholas Hospital
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Clinic Stevens Point Center
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Macomb Hematology Oncology PC
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Ann Arbor
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Genesis Healthcare System Cancer Care Center
mi
from
Zanesville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of NKTR-262 in Combination With NKTR-214 and With NKTR-214 Plus Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumor Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of NKTR-262 in Combination With NKTR-214 and With NKTR-214 Plus Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumor Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Safety Study of Talimogene Laherparepvec Combined With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hillman Cancer Center / University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer Clinical Trial
A Safety, Pharmacokinetic, Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Investigational Pharmacy Services
mi
from
Houston, TX
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Maryland Greenebaum Comprehensive Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist MD Anderson Cancer Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Georgia Oncology Centers PC - Marietta
mi
from
Marietta, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC Hillman Cancer Center Uniontown
mi
from
Uniontown, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Coffeyville Regional Medical Center
mi
from
Coffeyville, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Sanford South University Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Essentia Health - Fosston
mi
from
Fosston, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Bon Secours DePaul Medical Center
mi
from
Norfolk, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
ProHealth Waukesha Memorial Hospital
mi
from
Waukesha, WI
Click here to add this to my saved trials
Inflammatory Breast Carcinoma Clinical Trial
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Lovelace Medical Center-Saint Joseph Square
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Inflammatory Breast Carcinoma Clinical Trial
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
McFarland Clinic PC - Ames
mi
from
Ames, IA
Click here to add this to my saved trials
Inflammatory Breast Carcinoma Clinical Trial
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Medical Center-Rice Lake
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Inflammatory Breast Carcinoma Clinical Trial
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Ascension Providence Hospitals - Southfield
mi
from
Southfield, MI
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology - Allen
mi
from
Allen, TX
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Summit Medical Group
mi
from
Florham Park, NJ
Click here to add this to my saved trials